ArticleEndocrine2024
Targeting DUSP5 suppresses malignant phenotypes of BRAF-mutant thyroid cancer cells and improves their response to sorafenib.
Pu Chen et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
2 papers cite it
this papercites it